The intellectual lineage of paradoxical pharmacology strategy [2]

Medical Hypotheses

Volumn 65, Issue 4, 2005, Pages 815-

  Yun, Anthony J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR;

ASTHMA; CLINICAL PROTOCOL; DRUG USE; HUMAN; LETTER; MEDICAL RESEARCH; PRIORITY JOURNAL; SMOKING; THEORY; TREATMENT INDICATION; VALIDATION PROCESS;

ADRENERGIC BETA-ANTAGONISTS; ASTHMA; HUMANS; PHARMACOLOGY, CLINICAL;

EID: 22544436401     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.05.004     Document Type: Letter

References (6)

1. A.J. Yun, P.Y. Lee, and K.A. Bazar Paradoxical strategy for treating chronic diseases where the therapeutic effect is derived from compensatory response rather than drug effect Med Hypotheses 64 5 2005 1050 1059 [Epub 5 November 2005]
2. R.A. Bond Is paradoxical pharmacology a strategy worth pursuing? Trend Pharmacol Sci 22 6 2001 273 276
3. P.Y. Lee, A.J. Yun, and K.A. Bazar Acute coronary syndromes and heart failure may reflect maladaptations of trauma physiology that was shaped during pre-modern evolution Med Hypotheses 62 6 2004 861 867
4. A. Abbott Beta-blocker goes on trial as asthma therapy Nature 432 7013 2004 7
5. A.J. Yun, K.A. Bazar, P.Y. Lee, A. Gerber, and S.M. Daniel The smoking gun: many conditions associated with tobacco exposure may be attributable to compensatory autonomic responses to nicotine Med Hypotheses 64 6 2005 1073 1079 [Epub 19 January 2005]
6. J.D. Doux, K.A. Bazar, P.Y. Lee, and A.J. Yun Can chronic use of anti-inflammatory agents paradoxically promote chronic inflammation through compensatory host response Med Hypotheses 65 2 2005 389 391 [Epub 8 April 2005].